Healthy Volunteers - Male and Female

3
Pipeline Programs
3
Companies
3
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
3
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Clene
CleneSALT LAKE CITY, UT
1 program
1
CNM-Au8Phase 11 trial
Active Trials
NCT02755870CompletedEst. Oct 2016
Orna Therapeutics
Orna TherapeuticsMA - Watertown
1 program
1
ORN252Phase 11 trial
Active Trials
NCT07439796Not Yet RecruitingEst. Mar 2027
Qilu Pharmaceutical
Qilu PharmaceuticalChina - Jinan
1 program
1
QLS7305 InjectionPhase 11 trial
Active Trials
NCT07313150Not Yet RecruitingEst. Dec 2027

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
Orna TherapeuticsORN252
Qilu PharmaceuticalQLS7305 Injection
CleneCNM-Au8

Clinical Trials (3)

NCT07439796Orna TherapeuticsORN252

A Study of ORN252 in Healthy Participants

Start: Mar 2026Est. completion: Mar 2027
Phase 1Not Yet Recruiting
NCT07313150Qilu PharmaceuticalQLS7305 Injection

A Phase I Trial of Subcutaneous QLS7305 in Healthy Adults

Start: Jan 2026Est. completion: Dec 2027
Phase 1Not Yet Recruiting
NCT02755870CleneCNM-Au8

A Phase I SAD and MAD Clinical Trial of CNM-Au8 in Healthy Male and Female Volunteers

Start: Apr 2015Est. completion: Oct 2016
Phase 1Completed

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

3 companies competing in this space